Your search matched 49 results
You might want to think twice about ignoring that call from a random number.
As some people near the end of their third month of lockdown, many COVID-19-related trends are starting to look quite different than they did toward the beginning of the pandemic.
The COVID-19 (coronavirus) outbreak continues to grow worldwide – recently declared by the World Health Organization as a global pandemic – with widespread personal, medical, and business implications.
With an increasing number of coronavirus cases popping up around the world, countries are taking action by leveraging innovative health tech to protect the safety of the public without compromising the care they need.
Virtual delivery requires you to rethink your content and approaches.
Leading Through Uncertainty Amidst the Global Pandemic | Perspectives
Communities across the world are facing unprecedented times with a global pandemic affecting over 100+ countries.
COVID-19: Optimizing Promotions with HCP Preferences | Perspectives
Understanding HCP concerns and preferences for personal promotions in the time of COVID-19.
In this episode of our Coronavirus Special Edition Series, Syneos Health CEO Alistair Macdonald discusses the unique decisions to be made as a pharmaceutical organization practicing corporate responsibility in the name of public health.
For four years, scientists at MIGAL, the Galilee Research Institute, had been working on a COVID-19 vaccine without knowing it.
To help Syneos Health public relations agencies and clients navigate the media relations landscape during the pandemic, we conducted a survey in which we asked journalists to share insights on their coverage of health, medical and pharma/biotech industry topics.
Meet Think Bank | Perspectives
Think Bank is an agile way to answer complex questions.
Demonstrating Value in the Real World | Perspectives
Life sciences companies have a variety of tools to demonstrate the value of their medicines in the real world, but any innovative agreement or study should definitively answer these five questions.
COVID-19: How are Payers Managing These Days? | Perspectives
How are payers responding to COVID-19?
Our Virtual Reality | Perspectives
Virtual collaboration isn’t the future of work – it's the wave of the present
In this episode in our Coronavirus Special Edition Series, Jodi Scarbrough, Director of Custom Research at Syneos Health, discusses the impact of the COVID-19 on the adoption of telemedicine and teledetailing, and how these platforms might play out post-pandemic.
Recommendations for activities to inform and engage
MM&M eBook: Marketing in a Crisis | In The Media
In the "Marketing in a Crisis" eBook by MM&M, Scott Page of GSW, a Syneos Health company, says: “We are in this business of healthcare because it is a higher calling."
Payer Priorities in a Pandemic | In The Media
What are payers focused on during the COVID-19 pandemic?
Best practices for avoiding the novel corona virus are fairly well publicized, but for people who have contracted COVID-19 guidance can be harder to come by.
With the dramatic impact that COVID 19 has had on work, school, social engagements, and overall life as we know it, one would think that people would be anxious to be vaccinated.
COVID-19 has accelerated the rate at which we’re seeing change happening around us.
The COVID-19 pandemic is steadily increasing our risk for a mental health crisis around the world.
Peer To Peer Insights in the COVID-19 Era and Beyond | Perspectives
COVID-19 has introduced an era of unprecedented events to industries across the globe.
Patients are often at risk when presented with mixed messages.
Is Your Mask Up to the Task? | Blog
Deciding when, where, and what mask to wear has been a large topic of discussion as we re-enter into the “New Normal.”
COVID-19 treatment regimens are underscoring the threat of antimicrobial resistance, which threatens to kill as many as 20 million people per year by 2050.
Novo Nordisk’s new diabetes drug seemed all set for launch in early 2020, a time nobody could plan for.
At a virtual conference hosted last month by the Milken Institute, which aims to create economic solutions to contemporary healthcare challenges, experts explored some post-COVID realities starting to materialize.
As the pandemic surged, New York City’s Mt.
The Department of Health and Human Services (HHS) has selected the Fors Marsh Group to handle the new $250 million coronavirus campaign.